Halozyme Therapeutics
HALO
$59.44
Share price
3.55%
Change (1 day)
79.14%
Change (1 year)
Categories
Market capitalization of Halozyme Therapeutics (HALO)
Market cap: $8.03 Billion
As of December 2022 Halozyme Therapeutics has a market cap of $8.03 Billion. This makes Halozyme Therapeutics the world's 1689th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Halozyme Therapeutics from 2004 to 2022
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2022 | $8.03 B | 41.97% |
| 2021 | $5.66 B | -1.95% |
| 2020 | $5.77 B | 138.2% |
| 2019 | $2.42 B | 14.48% |
| 2018 | $2.11 B | -26.59% |
| 2017 | $2.88 B | 125.44% |
| 2016 | $1.27 B | -42.39% |
| 2015 | $2.22 B | 83.06% |
| 2014 | $1.21 B | -29.34% |
| 2013 | $1.71 B | 127.01% |
| 2012 | $0.75 B | -23.31% |
| 2011 | $0.98 B | 23.79% |
| 2010 | $0.79 B | 48.02% |
| 2009 | $0.53 B | 18% |
| 2008 | $0.45 B | -17.66% |
| 2007 | $0.55 B | 0.1% |
| 2006 | $0.55 B | 404.64% |
| 2005 | $0.10 B | 1.3% |
| 2004 | $0.10 B |
End of Day market cap according to different sources
On Dec 2nd, 2022 the market cap of Halozyme Therapeutics was reported to be:
$8.36 Billion
$8.03 Billion
$8.03 Billion
$8.03 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $467.67 B | 5,719.02% | 🇺🇸 USA |
 Pfizer PFE | $285.77 B | 3,455.70% | 🇺🇸 USA |
 Eli Lilly LLY | $356.08 B | 4,330.58% | 🇺🇸 USA |
 Sanofi SNY | $114.09 B | 1,319.67% | 🇫🇷 France |
 Baxter BAX | $26.82 B | 233.82% | 🇺🇸 USA |
 MannKind Corp MNKD | $1.26 B | -84.22% | 🇺🇸 USA |